An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia.

Carcao, M D; Avila, L; Leissinger, C; Blanchette, V S; Aledort, L

Carcao, M D; Avila, L; Leissinger, C; Blanchette, V S; Aledort, L.

Affiliation

Carcao MD; Department of Paediatrics, Division of Haematology/Oncology and Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Canada.
Avila L; Department of Paediatrics, Division of Haematology/Oncology and Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Canada.
Leissinger C; Tulane University School of Medicine, New Orleans, USA.
Blanchette VS; Department of Paediatrics, Division of Haematology/Oncology and Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Canada.
Aledort L; Mount Sinai School of Medicine, New York, NY, USA.

Haemophilia ; 23(5): e444-e447, 2017 09.

Article in En | MEDLINE | ID: mdl-28439934

Subject(s)

Hemophilia A/complications; Hemophilia B/complications; Hemophilia B/immunology; Hemorrhage/complications; Hemorrhage/prevention & control; Internationality; Surveys and Questionnaires; Adult; Child; Female; Hemophilia A/drug therapy; Hemophilia A/immunology; Hemophilia B/drug therapy; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Surveys and Questionnaires / Hemophilia B / Internationality / Hemophilia A / Hemorrhage Limits: Adult / Child / Female / Humans / Male Language: En Journal: Haemophilia Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google